Castle Biosciences Inc (CSTL) — Cash Flow Reinvestment Rate
Castle Biosciences Inc (CSTL) has a Cash Flow Reinvestment Rate of 1.05x as of June 2026, reinvesting $15.97 Million (capex $8.65 Million plus investments $-7.32 Million) from operating cash flow of $15.20 Million. See Castle Biosciences Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Castle Biosciences Inc Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Castle Biosciences Inc across 4 annual periods. For the full cash flow conversion analysis, see Castle Biosciences Inc cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Castle Biosciences Inc (2019–2025)
Year-by-year capital reinvestment analysis for Castle Biosciences Inc. See Castle Biosciences Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.59x | $38.04 Million | $64.35 Million | $36.02 Million | ▼ -51.1% |
| 2024 | 1.21x | $78.46 Million | $64.87 Million | $28.33 Million | ▲ +25.6% |
| 2020 | 0.96x | $9.50 Million | $9.87 Million | $4.75 Million | ▲ +260.4% |
| 2019 | 0.27x | $1.87 Million | $7.01 Million | $937.00K | — |